Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.

Identifieur interne : 000531 ( Main/Exploration ); précédent : 000530; suivant : 000532

Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.

Auteurs : Subhashie Wijemanne [États-Unis] ; Laura J C. Wu ; Joseph Jankovic [États-Unis]

Source :

RBID : pubmed:24150997

English descriptors

Abstract

Haloperidol and pimozide are the only drugs currently approved by the U.S. Food and Drug Administration for treatment of Tourette syndrome (TS), but their potential side effects, which include tardive dyskinesia (TD), limit their use.

DOI: 10.1002/mds.25692
PubMed: 24150997


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.</title>
<author>
<name sortKey="Wijemanne, Subhashie" sort="Wijemanne, Subhashie" uniqKey="Wijemanne S" first="Subhashie" last="Wijemanne">Subhashie Wijemanne</name>
<affiliation wicri:level="2">
<nlm:affiliation>Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wu, Laura J C" sort="Wu, Laura J C" uniqKey="Wu L" first="Laura J C" last="Wu">Laura J C. Wu</name>
</author>
<author>
<name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation>
<country>États-Unis</country>
<placeName>
<settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24150997</idno>
<idno type="pmid">24150997</idno>
<idno type="doi">10.1002/mds.25692</idno>
<idno type="wicri:Area/PubMed/Corpus">000703</idno>
<idno type="wicri:Area/PubMed/Curation">000703</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000540</idno>
<idno type="wicri:Area/Ncbi/Merge">003D94</idno>
<idno type="wicri:Area/Ncbi/Curation">003D94</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">003D94</idno>
<idno type="wicri:Area/Main/Merge">000531</idno>
<idno type="wicri:Area/Main/Curation">000531</idno>
<idno type="wicri:Area/Main/Exploration">000531</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.</title>
<author>
<name sortKey="Wijemanne, Subhashie" sort="Wijemanne, Subhashie" uniqKey="Wijemanne S" first="Subhashie" last="Wijemanne">Subhashie Wijemanne</name>
<affiliation wicri:level="2">
<nlm:affiliation>Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Parkinson's Disease Center and Movement Disorders Clinic, Baylor College of Medicine, Houston, Texas</wicri:regionArea>
<placeName>
<region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Wu, Laura J C" sort="Wu, Laura J C" uniqKey="Wu L" first="Laura J C" last="Wu">Laura J C. Wu</name>
</author>
<author>
<name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
<affiliation>
<country>États-Unis</country>
<placeName>
<settlement type="city">Houston</settlement>
<region type="state">Texas</region>
</placeName>
<orgName type="university" n="3">Baylor College of Medicine</orgName>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Dopamine Antagonists (adverse effects)</term>
<term>Dopamine Antagonists (therapeutic use)</term>
<term>Female</term>
<term>Fluphenazine (adverse effects)</term>
<term>Fluphenazine (therapeutic use)</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
<term>Tourette Syndrome (drug therapy)</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en">
<term>Dopamine Antagonists</term>
<term>Fluphenazine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Dopamine Antagonists</term>
<term>Fluphenazine</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Tourette Syndrome</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Aged</term>
<term>Child</term>
<term>Child, Preschool</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Retrospective Studies</term>
<term>Treatment Outcome</term>
<term>Young Adult</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Haloperidol and pimozide are the only drugs currently approved by the U.S. Food and Drug Administration for treatment of Tourette syndrome (TS), but their potential side effects, which include tardive dyskinesia (TD), limit their use.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Texas</li>
</region>
<settlement>
<li>Houston</li>
</settlement>
<orgName>
<li>Baylor College of Medicine</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Wu, Laura J C" sort="Wu, Laura J C" uniqKey="Wu L" first="Laura J C" last="Wu">Laura J C. Wu</name>
</noCountry>
<country name="États-Unis">
<region name="Texas">
<name sortKey="Wijemanne, Subhashie" sort="Wijemanne, Subhashie" uniqKey="Wijemanne S" first="Subhashie" last="Wijemanne">Subhashie Wijemanne</name>
</region>
<name sortKey="Jankovic, Joseph" sort="Jankovic, Joseph" uniqKey="Jankovic J" first="Joseph" last="Jankovic">Joseph Jankovic</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000531 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000531 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:24150997
   |texte=   Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:24150997" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024